The Fast Pace of Biotech The biopharmaceutical industry has embraced the adage of “Don’t be afraid of change, welcome it.” In doing so, the industry …

In this white paper, Broughton summarises the ‘historical’ development plan for pharmaceuticals, the changes that have occurred with regards to differential development including the requirements …

Biologics are a broad class of therapeutic agents, encompassing vaccines, monoclonal antibodies, therapeutic proteins, nucleic acid-based therapies, blood components, tissue therapies, and cellular therapies. Recently, …

Developing a drug can take years and comes with significant costs. During the early phases of this journey, it is vital to have a robust …

Optimised development and manufacturing processes that accelerate biologic production timelines while keeping costs down are critical to meeting the market demand. Streamlining drug product (DP) …

  Åsa Bergström, Director of Sustainability, Recipharm explores how pharmaceutical companies can address challenges to making a meaningful contribution to global carbon emissions reduction. As …

Gene-modified cell therapy for the treatment of cancer and other diseases is a rapidly growing area of clinical research. The therapeutic use of engineered cells …

The Model T Ford is still discussed in business schools today because of how Henry Ford relentlessly drove quality and innovation. When first introduced in …